We counsel clients ranging from biotech pharmaceutical companies to medical device manufacturers in a variety of areas including: choice of entity, corporate formation and structure and corporate governance; raising capital, including private/preferred stock investments, debt financings, venture capital and subsequent equity follow-on financings; due diligence and mergers and acquisitions; technology licensing, strategic alliances, R&D collaborations, joint ventures, clinical study agreements and supply and distribution agreements; and executive compensation and equity incentive arrangements.

We advise physicians and medical groups on initial formation of professional corporations. We have also represented physicians, medical groups and management companies in the negotiation of physician employment and recruitment agreements and management services agreements.

We provide legal advice to healthcare entities regarding compliance with the California “Speier” and federal “Stark” laws against self-referral, federal anti-fraud and abuse laws, and state and federal laws regarding privacy and security of protected health information, such as the Health Insurance Portability and Accountability Act. 

Our attorneys are also regular outside counsel on international contracts to a number of pharmaceutical companies and subsidiaries of foreign pharmaceutical companies in Mexico, and have conducted seminars at some of those companies on compliance with the Foreign Corrupt Practices Act.